Zydus Lifesciences Limited
NSE: ZYDUSLIFE | Information Technology
Market Fundamentals
Stock Intelligence & News
Zydus Lifesciences Limited
Zydus Lifesciences Limited has informed the Exchange regarding 'Public Announcement on Buyback'. |SUBJECT: Updates
Read Full Analysis →Sakar Healthcare Limited
Sakar Healthcare Limited has informed the Exchange about Sakar enters it s 40th agreement signed with Zydus Lifesciences to cater oncology products to GCC and other emerging markets, in parallel to building momentum on strong execution and expanding Business Opportunities |SUBJECT: General Updates
Read Full Analysis →Zydus Lifesciences Limited
Zydus Lifesciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Broker’s call: Zydus Lifesciences (Accumulate)
Domestic formulation delivered growth of about 14% y-o-y. Consumer business grew by 61% YoY. There was full quarter of Comfort click consolidation performance
Read Full Analysis →Zydus Lifesciences Limited
ZYDUS LIFESCIENCES LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL |SUBJECT: Update-Acquisition (including agreement to acquire)-XBRL
Read Full Analysis →Zydus Lifesciences Limited
Zydus Lifesciences Limited has informed the Exchange about General Updates |SUBJECT: General Updates
Read Full Analysis →Zydus Lifesciences Limited
Zydus Lifesciences Limited has informed the Exchange about General Updates |SUBJECT: General Updates
Read Full Analysis →Zydus Lifesciences Limited
Zydus Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Zydus Lifesciences,3 stocks hit 52-week highs, rally up to 25% in a month
Zydus Lifesciences,3 stocks hit 52-week highs, rally up to 25% in a month
Read Full Analysis →Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?
Zydus Lifesciences shares climbed to a new 52-week high. The company reported a 9% rise in net profit and over 16% revenue growth for the January-March quarter. A Rs 1,100 crore share buyback was announced. Analysts from Nomura, Nuvama, Motilal Oswal, and JM Financial shared their views on the company's performance and future prospects.
Read Full Analysis →Get instant alerts when ZYDUSLIFE breaks news
Join investors who track Zydus Lifesciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for ZYDUSLIFE?
ZYDUSLIFE is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Zydus Lifesciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding ZYDUSLIFE to your custom watchlist.